A detailed history of Allworth Financial LP transactions in Insmed Inc stock. As of the latest transaction made, Allworth Financial LP holds 69 shares of INSM stock, worth $5,119. This represents 0.0% of its overall portfolio holdings.

Number of Shares
69
Previous 53 30.19%
Holding current value
$5,119
Previous $3,000 66.67%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$62.0 - $79.01 $992 - $1,264
16 Added 30.19%
69 $5,000
Q2 2024

Jul 23, 2024

BUY
$22.0 - $69.71 $88 - $278
4 Added 8.16%
53 $3,000
Q1 2024

Apr 25, 2024

BUY
$25.72 - $29.94 $128 - $149
5 Added 11.36%
49 $1,000
Q3 2023

Oct 31, 2023

SELL
$19.86 - $26.93 $178 - $242
-9 Reduced 16.98%
44 $1,000
Q2 2023

Jul 18, 2023

BUY
$16.44 - $21.1 $147 - $189
9 Added 20.45%
53 $1,000
Q4 2022

Jan 13, 2023

SELL
$16.98 - $23.15 $169 - $231
-10 Reduced 18.52%
44 $0
Q3 2022

Oct 18, 2022

BUY
$20.88 - $28.21 $1,127 - $1,523
54 New
54 $1,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10.1B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Allworth Financial LP Portfolio

Follow Allworth Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.